About Evrim Kadriye Tezcanlı, M.D.
Prof. Evrim Kadriye Tezcanlı is a board-certified radiation oncologist with a long-standing commitment to patient-centered cancer care. She graduated from Marmara University Faculty of Medicine in 2005 and completed specialized training in Radiation Oncology. Since 2020, she has been practicing at Acibadem Health Group, where she provides advanced radiation therapy and collaborates with multidisciplinary teams to design individualized treatment plans. Prof. Tezcanlı is an active member of the Radiation Oncology Society and the Turkish Oncology Society, contributing to professional development and staying current with advances in cancer treatment. Known for her clinical expertise and compassionate approach, she focuses on combining evidence-based techniques with attention to patients’ quality of life.
Education
- 2005 Marmara University Faculty of Medicine Radiation Oncology
- 1995 – 2000 Istanbul University Istanbul Faculty of Medicine
- 1992 – 1995 Gazi Anatolian High School
Experience
- 2020 Acibadem Health Group
Memberships
- Radiation Oncology Society
- Turkish Oncology Society
Publications
- Tolerability and efficacy of temozolomide in high-grade relapsed glims
E. Tezcanlı, U. Abacıoğlu, H. Çağlar, P.F. Yumuk, M. Şengöz, XVI: National Cancer Congress 2005, P106 - Characteristics of patients with nasopharyngeal tumors who underwent stereotactic radiosurgery after external radiotherapy
B. M. Atasoy, E. Tezcanlı, Z. Akgün, S. Peker, U. Abacıoğlu, T. Kılıç, M. Şengöz, N. Pamir, XVI National Cancer Congress 2005, P92 - Outcomes of chemoradiotherapy for patients with bladder tumors
İ. Çetin, Z. Akgün, H. Çağlar, E. Tezcanlı, U. Abacıoğlu, M. Şengöz, F. Yumuk, S. Turhal, XVI. National Cancer Congress 2005, P60 - Prognostic signifiance of MIB-1 labeling indices for oligodendroglial tumors
Abacioglu U, Sengoz M, Tezcanli E, Akbulat S, Peker S, Sav A, Proceeding ASCO, 122s, Orlando, 2005 - Toxicity and survival outcomes of radiotherapy and concurrent gemcitabine in patients with locally advanced pancreatic cancer
H. Çağlar, U Abacıoğlu, E. Tezcanlı, F. Yumuk, S. Turhal, M. Şengöz, 6th National Radiation Oncology Congress - Turkish translation and pilot-test study of EORTC colorectal cancer module QLQ-CR 38” in evaluating the quality of life of colorectal cancer patients, 6th National Radiation Oncology Congress
U Abacıoğlu, Ö,.F. Odabaş, E. Tezcanlı, F. Yumuk, H. Çağlar, P.F. Yumuk, M. Şengöz, S.Tufhal - Ki-67 proliferation index as a prognostic factor in Glioblastoma Multiforme
Abacioglu U, Sengoz M, Tezcanli E, Akbulut S, Peker S, Sav A. Perspective in Central Nervous System Malignancies, 166, Prague, 2005 - Tolerability and efficacy of temozolomide in high-grade recurrent gliomas
U. Abacıoğlu, M. Şengöz, E. Tezcanlı, H. Çağlar, P.F. Yumuk, 6th National Radiation Oncology Congress, P223
